rs180177304
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_012203.2(GRHPR):c.102G>A(p.Trp34*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,270 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_012203.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- primary hyperoxaluria type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_012203.2. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GRHPR | TSL:1 MANE Select | c.102G>A | p.Trp34* | stop_gained | Exon 2 of 9 | ENSP00000313432.6 | Q9UBQ7-1 | ||
| GRHPR | TSL:1 | n.129G>A | non_coding_transcript_exon | Exon 2 of 9 | |||||
| GRHPR | TSL:1 | n.159G>A | non_coding_transcript_exon | Exon 2 of 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461072Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 726866 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74354 show subpopulations
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at